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A method has been developed for the determination of the rate of formation ol’deohyadrnosinc from dATP in cultured cell lines. The lowest rate 
was found in the T-cell-derived Molt cell line while it was about 70.fold higher in Bulb c/3T3 mouse iibroblasts. In the B-cell-derived Raji cells 
and in the murinc sarcoma cell line SEWA it had intermediary values. It is concluded that in some cell types like the 3T3-cells the catabolism of 
dATP to deoxyadcnosine may have a significant regulatory effect on the cellular content of dATP, 
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1. INTRODUCTION 
The de novo synthesis of the substrates for DNA 
replication, the four deoxyribonucleoside triphosphates 
(dNTPs), depends on ribonucleotide reductase, an en- 
zyme the activity of which is highly regulated and sub- 
ject to a complicated allosteric control [l]. The enzyme 
seems to play a major role in maintaining a fine tuned 
balance between the pools of the dNTPs during the 
S-phase of the cell cycle of mammalian cells [2]. This 
balance may, however, be impaired in growing cells if 
a deoxyribonucleoside is available, resulting in reduced 
replication of DNA. This was first observed for deoxya- 
denosine which in Ehrlich ascitcs tumor cells gives rise 
to the accumulation of large amounts of dATP [3]. This 
compound exerts a pronounced feed-back inhibition of 
ribonucleotide reductase and it leads consequently to 
the prevention of DNA replication due to lack of the 
other three dNTPs [2]. Degradation of DNA in vivo as 
it occurs during the formation of erythrocytes leads to 
the formation of deoxyribonucleoside mono- 
phosphates, which are further degraded. The catab- 
olism of dAMP seems to exclusively lead to the forma- 
tion of deoxyadenosine [4]. In normal organisms and 
cells adenosine deaminase prevents the accumulation of 
deoxyadenosine which is eventually cor.verted to hy- 
poxanthine and deoxyribose ;&tisp;<-btes. However, in- 
dividuals suffering from. inherited aiienosine deaminase 
deficiency contain in the blood dec;;xyadenosine which 
may be phosphorylated to dATP. It accumulates in rel- 
atively large amounts in especially T-lymphocytes and 
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in other blood cells. Under these conditions the normal 
function of lymphocytes is curtailed. Adenosine 
deaminase deficiency is, thus, a potential lethal in- 
herited disorder associated with combined immunode- 
ficiency [S]. The phosphorylation of deoxyadenosine to
dAMP is probably mainly catalyzed by deoxycytidine 
kinase which in addition has deoxyguanosine as a sub- 
strate [6]. Evidently, under conditions resembling par- 
tial or complete adenosine deaminase deficiency, the 
rate of phosphorylation of deoxyadenosine may exceed 
that of dephosphorylation of dAMP in cells like periph- 
eral lymphocytes [73 as well as in cultured transformed 
lymphocytes [8] and in Ehrlich ascites tumor cells [9]. 
Estimates of the rates of degradation of high concentra- 
tion of dATP induced by deoxyadenosine has previ- 
ously been made in different cell lines after the removal 
of deoxyadenosine from the growth medium. In the 
present work we have determined the rate of degrada- 
tion of dATP to deoxyadenosine isI four different cell 
lines growing in normal media, i.e. in the absence of 
added deoxyadenosine. 
2. MATERIALS AND METHODS 
Balb c/3T3 mouse libroblasl cells were grown in DME medium 
ccnluining 10% newborn calf serum. For experiments. cells were 
treated as follows. Confluent cultures were lrypsinizcd, diluted and 
transferred to 24-cm’ flasks at a density of 3 x IO’ tills in 5 ml: aRer 
18 h approximately 47% of the cells were in the S-phase of the cell 
cycle. The transformed human thymocyee and lymphocyte cell lines, 
Raji and Molt, respectively and the muiinc sarcoma cell line SEWA 
[IO] were grown as suspension cuhurcs in RPM1 medium containing 
10% fetal calf serum. During the cxpcrimenls the cell densities were 
about IW cells pa- ml and close to 40% ofthe cells were in the S-phase 
of the ccl! cycle as drtemlined by flow cytometry. Cells wcrc prclabclcd 
for IS h with [I-“Hladenine (0.2 PM. 42 Ci per mmol). After chan&e 
of ~hc medium cofonnycin was added at a concentration of 0.1 NM 
Published by Elscvier Sc;mce F~~blislrrrs B. V. 143 
Volume 299, number 2 FEBS LETTERS 
Tnhlc I 
March 1992 
Cell line 3T3 SEWA Raii Molt 
Average content of dATP (pmol x (I Oh cells)-‘) 
Cells in S-phase (per cent) 
Average specific radiotictivity of dATP (cpm x pmol-I) 
Rate of formation of radioactive deoxyadcnosinc from d.4TP 
(lo’ cpm x ( 10b cells)-’ x h-l) 
ZO 21 
(34;26) (21,21) (47::4) 
47 39 38 39 
192 413 380 202 
72 IO 20 I.1 
Rate of formation of deoxyadenosine from dATP 
during the S-phase (pmol x (IO” cells)-’ x h-l) 
Fraction of dATP that is degraded to dcoxyadcnosinc 
!per cent of the sum of dAMP incorporated into DNA plus 
the amount degraded to dcoxyadenosine)* 
800 139 
(787,813) (I651 13) (8.3l,?Q) 
56 II I8 2 
_- 
The experimental figures are the average of4 experiments with SEWA cells (S.E.M. is given in parentheses) and of 2 experiments with each of 
the other cells (the individual results are given in parentheses). 
*These figures are based on a cellular DNA content of 6 pg and a molar adcninc content in DNA of 28% [Is]. Thus, IO6 G,-phase cells contain 
5.8 nmol ofdAMPand the average rate of incorooration ofdAMP in to DNA during the S-phase of the cell cycle (assuming itto be 9 h) 1s accordingly 
- 640 pmol per h per lOn cells. 
or more and incubation was continued for 6 h. dATP was extmctcd 
from cells by a moditication of the method of North ct al. [I I], At least 
IO’ cells were extracted for 30 min with 60% methanol (4OC), the 
extract was centrifuged nnd the supernatant evaporated to dryness. 
The residue was treated with 2% perchloric acid (4°C) for 30 min. 
neutralized and centrifuged. The resulting supernatant was eva- 
porated to dryness and the residue used for enzymatic determination 
of dATP its described [I I] using the large fragment of DNA po- 
lymcrasu I and the alternating copolymer poly(dA-dT) as primer 
template. The specific rddiodctivity of dATP in the extract was ob- 
tained from the total radioactivity (as determined in the presence of 
unlabeled dTTP) and from the total amount (as dctermincd with 
[‘H]dTTP (IO Cilmmol). Analyses of parallel experiments performed 
with cells that had not been prelabelcd with [“Hjadenine resulted in the 
same figure for the amount of dATP. The lH~labeled eoxyadenosine 
that ticcumulated inthe mrdium after medium change was determined 
after its isolation on a reversed-phase column. Isocratic lution (0. I5 
M potassium phosphate, pH 4.0; I% methanol, I% acetonitrile, 0.2% 
tetrahydrofuran) was employed. 
3. RESULTS AND DISCUSSION 
The design of the experiments were as follows. The 
cellular adenine ribonucleotides and deoxyribonu- 
cleotides were labeled by pretreatment of cultured cells 
with [2-3H]adenine. After change of the growth 
medium, the incubation was continued in medium ccn- 
taining coformycin at a concentration that prevented 
deamination of any 2’-deoxyadenosine that might be 
formed. At the beginning of the experiment and after 
incubation of the cells For 3 and 6 h, low molecular 
compounds were extracred from the cells and the con- 
tent and the radioactivity* of dATP was determined. Any 
deoxyadecosine accumulated during the experiment 
was isolated from the growth mediurl and its radioac- 
tivity was determined. The amount cdf deoxyadenosine 
formed from dATP during the cxpe.riment was deter- 
144 
mined from its radioactivity and from the average spe- 
ciftc radioactivity of dATP. 
The experimental results appear from Table I which 
shows that the average content of dATP ranged from 
6.5 to 45 gmol per lo6 cells, with the lowest content in 
the SEWA cells and the highest in 3T3 cells. Since nu- 
cleotide reductase is active only during the S-phase of 
the cell cycle it seems justified to assume that dATP is 
present in the cells in normal growth medium only dur- 
ing this period. On this assumption and from the frac- 
tion of cells in the S-phase, the dATP content and the 
rate of formation of deoxyadenosine has been calcu- 
lated during this phase of the ccl: cycle. It appears that 
in the T-cell-derived Molt cells the rate of formation of 
deoxyadenosine is about 60-fold lower than in the 3T3 
fibroblasts while in the SEWA and B-cell derived Raji 
cells the rates were about 13- and 6-fold lower, respec- 
tively. The experiments howed a constant rate of 2’- 
deoxyadenosine formation in the experimental period 
and the specific radioactivity of dATP did not change 
in a systematic way (data not shown). In the presence 
of hydroxyurea (0.5 mM), no labeled deoxyadenosine 
was formed in experiments with 3T3 cells (data not 
shown). Since hydroxyurea is a speciftc inhibitor of nu- 
c!eosidediphosphate r ductase, this confirms that the 
deoxyadenosine as measured in the present work stems 
from dATP formed by de novo synthesis catalyzed by 
the reductase reaction. With SEWA cells it was found 
that the amount of labeled deoxyadenosine that ac- 
cumulated in the medium varied less than 9% when the 
concentration of coformycin was 0.1, I .O and 25 /I’M. 
This is in agreement with the assumption that dAMP is 
degraded exclusively to deoxyadenosine and not to 
dIMP [4]. The activity of adenosine deaminase isknown 
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to be inhibited completely by 0.1 yM coformycin while 
that of AMP deaminase is inhibited at 25-50,uM cofor- 
mycin [12]. In the present experiments cofomycin was 
found to have no effect on the cellular dATP content. 
The results show, finally, that for the 3T3 fibroblasts the 
amount of dATP which is degraded to deoxyadenosinc 
is similar to the amount that is incorporated into DNA 
as (IAMP, This is in sharp contrast to the finding for 
especially Molt cells where only a few per cent of dATP 
is cataboiized while in the two other cell lines inter- 
mediate figures were obtained. These findings may indi- 
cate that in some cell types like fibroblasts the rate of 
catabolism of dATP to deoxyadenosine may have a 
significant regulatory effect on the cellular content of 
dATP. In other types of cells like the transformed lym- 
phocyte, Molt, this regulation may almost exclusively 
come about through an allosteric feed-back regulation 
of the ribonucleotide reductase. For 3T6 fibroblasts in 
the S-phase of the cell cycle, Nicander and Reichard [131 
and Bianchi et al. [14] have similarly found that the 
synthesis of pyrimidine deoxyribonucleotides was larger 
than their demand for DNA synthesis and that the cells 
degraded the surplus material to deoxyribonucleosides. 
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